Within Penn States College of Medicine, three female researchers won Whitaker Centers Women of Impact: Celebrating Women in STEM Awards for their advancement in the field, which Elizabeth Proctor said was an honor.
Proctor said she received the Game Changer award under the Whitaker Centers Women of Impact in September 2021 for her research on Alzheimer's disease.
I was really honored and happy that people saw this worth in my work, Proctor, assistant professor of neurosurgery, pharmacology, biomedical engineering, and engineering science and mechanics, said.
For Proctor, shes really passionate about studying Alzheimers disease and the different moving pieces in the disease.
Proctor received her bachelor's degree from Purdue University and Ph.D. in biophysics from the University of North Carolina at Chapel Hill, and then she held a postdoctoral position at the Massachusetts Institute of Technology.
One reason Proctor developed an interest in studying Alzheimers disease was watching individuals in her family who were personally affected.
It is so common, and we have no cure, Proctor said. Its a horrible thing to lose yourself, and that is what Alzheimers takes from people.
Proctor said she also saw a gap that somebody with her skill set could fill in the research and her goal became to figure out how all the pieces fit together.
While completely respecting all the community that has come before, I thought there is this one piece that maybe I could help that I haven't seen anyone else doing, and I am uniquely suited to do it, Proctor said.
She said she wanted to learn what causes patients to present cognitive deficits, memory impairment and all these things that drive people to go to a doctors office and say, I am sick, I need help.
MORE NEWS COVERAGE
Growing up, Ana Wakeman said she was taught the Complementarian view that women are equally
What we are trying to do is make this overall map and try to understand how we could affect the entire disease and actually try to fix it in a way that would address all these issues and ultimately make cognition better, Proctor said.
Proctor said in her research lab, she tries to measure at the molecular level different processes that are dysregulated in the disease, using everything from cells to organoids to animals.
We have not done human samples yet, but we hope to in the future, Proctor said. And we try to use all these different systems to untangle all of the processes that are being dysregulated.
Within her research, Proctor said shes trying to come in and do something that has never been done before and potentially make a very large impact on the way the field understands science which is why she believes she won the award.
I am trying to unite people who do more molecular and cellular work with people who do my physiological research, Proctor said. In the way that I have been trying to do this with computational science, it hasnt been done before.
While Proctor said she wont cure Alzheimers or completely change the field herself, rather, she intends to contribute to the advancement of understanding the disease.
I am not coming in and trying to rescue anything, but I think there are things that I could do that arent being done right now that maybe I am uniquely suited for, Proctor said.
Dr. Shou Ling Leong was also a recipient of the Game Changer award as a result of helping create curriculum for the three-year accelerated medical pathway.
Leong, assistant dean for pathways innovation in the College of Medicine, associate vice chair for education, director of longitudinal and 3+ accelerated pathways, and professor of family and community medicine, said she was thrilled to receive the award.
You never know about these things, Leong said. When you get nominated, you feel that people value what you have done and recognize the impact you have made, but when it is finally validated, it's a joy.
Leong said she wears many hats, such as clinical work, education and research, but what she loves the most is to innovate and develop new things.
She develops new programs, one being the three-year program, and she also conducts assessments and research to make sure the programs are impactful and have measurable outcomes.
For example, with the three-year program, we have done big studies to make sure that students indeed get a good education, Leong said. So after they graduate, they have the competency to be excellent doctors but also satisfied with their curriculum and not stressed and burnt out.
Inspiration for the three-year program came primarily from the news, Leong said, because there has been talk [in the media] that we dont have enough physicians particularly primary care physicians.
We know that students are graduating with huge amounts of debt, so I want to address those things, Leong said. It became clear to me that by having a three-year program, it would address both of those issues and others, too.
By graduating a year early, students save quite a bit of money and in the process, help to address the physician shortage, Leong said.
Leong said the three-year program has really made a difference in medical education and reframed how we look at medical education which is why she believes she was a recipient of the award.
I feel very proud and very happy to have gotten the award, Leong said.
Jennifer Moss had been named the Women to Watch Class of 2021 under the Whitaker Centers Women of Impact, which is given to a scientist in their early career.
MORE NEWS COVERAGE
Penn State international student Emily Davis said going to an American school has been [her
Moss, assistant professor in the department of family and community medicine, and the department of public health sciences at Penn State, said she conducts research on the impact of geography and community factors on cancer prevention and cancer outcome.
Trying to identify what it is about certain communities particularly rural communities that make them more susceptible to elevated rates of cancer incidents and cancer mortality is the center of her research, Moss said.
What shes found is a complex web of factors that influence what makes people more or less likely to engage in behaviors that prevent cancer, such as vaccination, physical activity and screening behaviors, and how they translate into different incidents and mortality, Moss said.
Moss was born in a rural community in Texas and moved around a lot, which is what prompted her to research how cancer affects various populations.
The difference in life expectancy and cancer rates for someone where I was born versus where I got my training were really stark, and it prompted me to think about what I could do with training in behavioral science and social epidemiology in order to reduce the higher rates of cancer we see, and that is what I try and do with my work identify the causes of these disparities and solutions, ways that we can get health care services to people living in rural communities, Moss said.
Moss has been working with small clinics in Pennsylvania to evaluate how feasible it is for patients, particularly in rural and isolated communities, to use at-home tests for screening of cancer so they dont have to travel to a doctors office to get screened.
It really empowers patients in rural communities to get tested, and if they do have cancer, we can identify it and diagnose it earlier, Moss said.
Moss said she was very thrilled to receive the award.
I was nominated by the chair of my department, who has always been very supportive of my work and my career, so it was great to get that recognition from the community and join this sort of cohort of women who received awards from the Whitaker Center, Moss said.
The Whitaker Center continues to do a lot of work to support women in science, according to Moss.
Not just for us who are professionals but also for girls and young women who are still learning about the potential careers in science.
MORE NEWS COVERAGE
Twenty-seven-year-old Amanda Atkinson said despite being old enough to be their babysitter,
If you're interested in submitting a Letter to the Editor, click here.
Go here to see the original:
Penn State recipients of Whitaker Center's Women of Impact 2021 awards unite through research - The Daily Collegian Online
- Kyle Orwig received the Distinguished Researcher Award from the American Society for Reproductive Medicine - University of Pittsburgh - October 4th, 2022
- I Have Cancer And I'm Thankful For The Life Science Industry - Clinical Leader - July 19th, 2022
- Whitmer to veto adoption, abortion alternative funds from Michigan budget - Bridge Michigan - July 19th, 2022
- Tevogen Bio Appoints Acclaimed Oncologist and Immunotherapy Expert Neal Flomenberg, M.D. as Chief Scientific Officer and Global Head of R&D - Yahoo... - July 11th, 2022
- Amendment added to PA budget bill would make Pitt, other universities stop fetal tissue research - WPXI Pittsburgh - July 3rd, 2022
- Free Fecal Water Syndrome in Horses and What To Do About It The Horse - TheHorse.com - July 3rd, 2022
- PAWcast: Valedictorian Natalia Orlovsky '22 on Research, Mental Health, and Pandemic Princeton - Princeton Alumni Weekly - July 3rd, 2022
- Opinion | Pro-Life Representatives may be the reason thousands of students cant afford Pitt - The Pitt News - June 22nd, 2022
- Tackling chronic disease with gene and cell therapies - The Irish Times - May 2nd, 2022
- How one inflammatory disorder exacerbates another | Penn Today - Penn Today - May 2nd, 2022
- ChristianaCare and The Wistar Institute Advance Partnership With New Cancer Research Strategies - ChristianaCare News - March 25th, 2022
- The Incredible Story of Emily Whitehead & CAR T-Cell Therapy : Oncology Times - LWW Journals - March 25th, 2022
- Citius Pharmaceuticals to Host Key Opinion Leader Webcast on the Compelling Need to Salvage Central Venous Catheters in CLABSI Patients - Stockhouse - October 28th, 2021
- NIH, FDA and 15 private organizations join forces to increase effective gene therapies for rare diseases - National Institutes of Health - October 28th, 2021
- FDA, NIH, and 15 private organizations join forces to increase effective gene therapies for rare diseases - FDA.gov - October 28th, 2021
- People and places at Penn | Penn Today - Penn Today - Penn Today - August 18th, 2021
- Millions in federal money flowed to tissue bank that collected fetal 'heart, gonads, legs, brain': report - Fox News - August 5th, 2021
- Bispecific Antibodies Wage a Two-Pronged Attack on Tumors - Curetoday.com - June 23rd, 2021
- Newly Discovered Glycosylated RNA Is All Over Cells: Study - The Scientist - May 25th, 2021
- Penn researchers find a way through the labyrinth keeping CAR-T from solid tumors - Endpoints News - December 7th, 2020
- 'Benjamin Button' discovery could reverse ageing process - Queensland Times - December 7th, 2020
- The story of mRNA: From a loose idea to a tool that may help curb Covid - STAT - November 11th, 2020
- Dr. Andreas Sauerbrey: The right orthopaedic diagnosis is essential to proper care - Sky Hi News - September 12th, 2020
- T cells, B cells and the range of the human bodys immune response A simple decoder - ThePrint - August 10th, 2020
- Are very long-lived trees immortal and what can they teach humans? - ABC News - August 10th, 2020
- Eradicating balding a step closer with new procedure in the cross hairs - The New Daily - June 4th, 2020
- Coming Together to Solve COVID-19 Mysteries | University of Pennsylvania Almanac - UPENN Almanac - June 4th, 2020
- Orthopedics - Pennsylvania Stem Cell Center - May 25th, 2020
- Stem Cell Treatment Bala Cynwyd | Stem Cell Therapy ... - May 25th, 2020
- Vasomune Therapeutics Announces Clinical and Scientific Advisory Board - BioSpace - May 11th, 2020
- Chinas scientists accused of playing God by creating monstrous cloned apes and primates with human organs - The Sun - May 11th, 2020
- Pregnant and positive | Scientists look for COVID-19 immunity in the womb - WHAS11.com - April 23rd, 2020
- Why Choose Us - Pennsylvania Stem Cell Center - April 10th, 2020
- Moderna: A $12 Billion Brand Built On Hope And mRNA - Seeking Alpha - April 10th, 2020
- The potential use of CRISPR to treat disease is gaining momentum - BioNews - January 16th, 2020
- What a time to be alive: Reproductive breakthroughs of the 2010s that changed life as we know it - FOX 10 News Phoenix - January 3rd, 2020
- 2019: The year gene therapy came of age - Jamaica Observer - December 9th, 2019
- Trevena Inc. (TRVN)'s Financial Results Comparing With VistaGen Therapeutics Inc. (NASDAQ:VTGN) - The Broch Herald - December 9th, 2019
- 253 miles in 4 hours: A Syracuse mans race for a lung transplant, and the angel who helped him - syracuse.com - December 1st, 2019
- Head to Head Survey: BioRestorative Therapies (OTCMKTS:BRTX) & Livongo Health (OTCMKTS:LVGO) - Mitchell Messenger - December 1st, 2019
- Critical Review: BioRestorative Therapies (OTCMKTS:BRTX) and Livongo Health (OTCMKTS:LVGO) - NCTY News - November 16th, 2019
- These Israeli Companies Are Finding Innovative Ways To Improve Diabetes Care, Treatment | Health News - NoCamels - Israeli Innovation News - November 16th, 2019
- Reviewing BioRestorative Therapies (OTCMKTS:BRTX) and Livongo Health (OTCMKTS:LVGO) - Mitchell Messenger - November 16th, 2019
- Reviewing Madrigal Pharmaceuticals Inc. (MDGL)'s and Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI)'s results - MS Wkly - October 30th, 2019
- Gene Therapy/Editing Series 1: A Brief Introduction To Gene Therapy - Seeking Alpha - October 30th, 2019
- AI uncovers genes linked to heart failure - FierceBiotech - September 27th, 2019
- University of Pennsylvania || Cell and Molecular Biology ... - September 7th, 2019
- Robert Lanza - Wikipedia - May 12th, 2019
- Cary Ortho Utilizes Bone Marrow Stem Cells for General ... - May 12th, 2019
- Stem Cell Therapy in Lancaster Pennsylvania | Stem Cell ... - April 24th, 2019
- Lung Institute Review | Do Stem Cell Treatments Work? - April 21st, 2019
- Cells Weekly October 11, 2015 - stemcellassays.com - February 5th, 2019
- Pittsburgh, Pennsylvania - Stem Cells Transplant Institute - November 18th, 2018
- Stem Cell Therapy in York County, Pennsylvania - October 8th, 2018
- Regrowing dental tissue with stem cells from baby teeth ... - October 2nd, 2018
- About Penn's IRM - Institute for Regenerative Medicine - September 16th, 2018
- Stem Cell Treatment - Philadelphia Bala Cynwyd, PA: World ... - August 13th, 2018
- Stem Cell Therapy in Conewago Township, Pennsylvania - July 19th, 2018
- Meetings - October 8th, 2017
- Tucson's Calimmune to be acquired by Australian drug giant - Arizona Daily Star - August 30th, 2017
- Hair Regrowth using Stem Cells | Ashley and Martin - August 30th, 2017
- Bone Marrow Protein May Be Target for Improving Stem Cell Transplants - Penn: Office of University Communications - August 30th, 2017
- Novartis receives first ever FDA approval for a CAR-T cell therapy, Kymriah(TM) (CTL019), for children and young ... - GlobeNewswire (press release) - August 30th, 2017
- COLUMN: Startling statistics concerning drug deaths in rural communities - Meadville Tribune - August 25th, 2017
- Rare leukemia targeted by modifying patients' immune cells - New Haven Register - August 7th, 2017
- Campus achievement - Sunbury Daily Item - August 7th, 2017
- La Jolla Light News Nuggets: July 27 - La Jolla Light - July 30th, 2017
- 2016 Scientific Program - December 4th, 2016
- Tissue Niches & Resident Stem Cells in Adult Epithelia - GRC - August 26th, 2016
- Knee Stem Cell Therapy and Platelet Procedures Pittsburgh ... - July 2nd, 2015
- Penn vet team points to new colon cancer culprit - March 16th, 2015
- MD Anderson Names Hwu as Head of Cancer Medicine - February 26th, 2015
- Stemiotics Licenses Modified RNA for Cell Reprogramming - December 22nd, 2014
- Penn Medicine Researchers Announce Latest Results of Investigational Cellular Therapy CTL019 - December 8th, 2014
- Cyanide killed hospital employee, official says - November 29th, 2014
- An Eclectic Path to Precision Medicine - November 25th, 2014
- First Study to Convert Adult Human Cells to Hair-Follicle ... - November 2nd, 2014
- Stem Cell and Xenograft Core: Biomedical Research Core ... - October 27th, 2014
- Immune Therapy Induces Remission for Many With a Tough-to-Treat Blood Cancer - October 18th, 2014
- Sangamo BioSciences ZFP Therapeutic Program in HIV/AIDS Featured at Three Major Scientific Conferences in October 2014 - October 16th, 2014